|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the provision of information by health and human |
|
services agencies to assist children with velocardiofacial |
|
syndrome. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subchapter D, Chapter 117, Human Resources Code, |
|
is amended by adding Section 117.076 to read as follows: |
|
Sec. 117.076. INFORMATION REGARDING VELOCARDIOFACIAL |
|
SYNDROME. (a) The commission shall ensure that each health and |
|
human services agency that provides intervention services to young |
|
children is provided with information developed by the commission |
|
regarding velocardiofacial syndrome. |
|
(b) Each health and human services agency described by |
|
Subsection (a) shall provide the information regarding |
|
velocardiofacial syndrome to appropriate health care coordinators |
|
and therapists and to parents of a child who is known by the agency |
|
to have at least two of the following conditions: |
|
(1) hypotonicity; |
|
(2) communication delay; |
|
(3) articulation disorder; |
|
(4) resonance disorder; |
|
(5) nasal regurgitation during feeding as an infant |
|
with no history of a cleft palate; |
|
(6) recurrent ear infections as well as diagnosis of |
|
cardiac anomaly, feeding disorder, cleft palate, or submucosal |
|
cleft palate; or |
|
(7) fine motor or gross motor skills delay. |
|
(c) The commission shall develop the information required |
|
under Subsection (a) using medically accurate, peer-reviewed |
|
literature. The information must include: |
|
(1) an explanation of velocardiofacial syndrome |
|
symptoms, diagnosis, and treatment options; |
|
(2) information on relevant state agency and nonprofit |
|
resources, parent support groups, and available Medicaid waiver |
|
programs; and |
|
(3) a recommendation for follow-up with a health care |
|
provider for evaluation of the underlying etiology and an |
|
explanation that the existence of any of the conditions listed in |
|
Subsection (b) will not necessarily result in a diagnosis of |
|
velocardiofacial syndrome. |
|
(d) The executive commissioner may adopt rules as necessary |
|
to implement this section. |
|
SECTION 2. This Act takes effect September 1, 2009. |